Methylation status of the PTEN gene in adenoid cystic carcinoma cells

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) is frequently inactivated in human cancers via mutations or epigenetic alterations.
• PTEN promoter hypermethylation is a key epigenetic mechanism causing gene silencing and contributing to tumorigenesis.
• Adenoid cystic carcinoma (ACC) is a type of cancer where PTEN's role and regulatory mechanisms are not fully understood.

Purpose of the Study:

• To investigate the involvement of PTEN promoter methylation in regulating PTEN gene expression in adenoid cystic carcinoma (ACC) cells.
• To determine if PTEN expression is reduced in ACC cells compared to normal salivary gland cells.
• To explore the potential of PTEN as a diagnostic marker for ACC.

Main Methods:

• RT-PCR analysis to compare PTEN mRNA levels in ACC cells and normal cells.
• Methylation-specific PCR (MSP) and direct sequencing to detect PTEN promoter methylation.
• Treatment of ACC cells with the DNA methylation inhibitor 5-aza-2-deoxycytidine.
• RT-PCR, Western blot, and luciferase assays to assess PTEN expression and promoter activity after inhibitor treatment.

Main Results:

• PTEN expression was significantly lower in ACC-2 cells compared to normal salivary gland epithelial cells.
• CpG island methylation was confirmed in the PTEN promoter region of ACC-2 cells.
• Treatment with 5-aza-2-deoxycytidine led to a time-dependent increase in PTEN mRNA, protein expression, and promoter activity in ACC-2 cells.

Conclusions:

• PTEN promoter hypermethylation is responsible for the reduced expression of the PTEN gene in ACC cells.
• This epigenetic silencing of PTEN contributes to the development of ACC.
• PTEN holds promise as a molecular marker for the early diagnosis of adenoid cystic carcinoma.